Growth Metrics

Neogen (NEOG) Net Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Neogen 1.94 Bn 1.78 Bn 99.00 Mn 198.35%

Historic Data

Download Data 🔒
DateValue
Feb 28, 2026 198.35%
Nov 30, 2025 -66.23%
Aug 31, 2025 118.15%
May 31, 2025 -116.94%
Feb 28, 2025 72.27%
Nov 30, 2024 -19.50%
Aug 31, 2024 -428.83%
May 31, 2024 -90.68%
Feb 29, 2024 -16.19%
Nov 30, 2023 640.42%
Aug 31, 2023 -77.50%
May 31, 2023 4,236.60%
Feb 28, 2023 -395.55%
Nov 30, 2022 68.69%
Aug 31, 2022 6,053.00%
May 31, 2022 125.75%
Feb 28, 2022 80.67%
Nov 30, 2021 -130.18%
Aug 31, 2021 79.12%
May 31, 2021 -93.28%
Feb 28, 2021 -170.74%
Nov 30, 2020 486.56%
Aug 31, 2020 -132.25%
May 31, 2020 129.03%
Feb 29, 2020 -50.27%
Nov 30, 2019 332.56%
Aug 31, 2019 -2.48%
May 31, 2019 -1,328.32%
Feb 28, 2019 -156.24%
Nov 30, 2018 -69.59%
Aug 31, 2018 190.89%
May 31, 2018 -76.37%
Feb 28, 2018 163.63%
Nov 30, 2017 -39.57%
Aug 31, 2017 -191.20%
May 31, 2017 252.50%
Feb 28, 2017 -587.21%
Nov 30, 2016 -60.59%
Aug 31, 2016 189.08%
May 31, 2016 -233.74%
Feb 29, 2016 -145.58%
Nov 30, 2015 857.29%
Aug 31, 2015 -283.82%
May 31, 2015 433.95%
Feb 28, 2015 1,745.98%
Nov 30, 2014 -930.16%
Aug 31, 2014 297.50%
May 31, 2014 -314.18%
Feb 28, 2014 -106.71%
Nov 30, 2013 88.59%
Aug 31, 2013 -40.03%
May 31, 2013 -81.22%
Feb 28, 2013 33.57%
Nov 30, 2012 -121.65%
Aug 31, 2012 66.24%
May 31, 2012 18.21%
Feb 29, 2012 87.50%
Nov 30, 2011 244.49%
Aug 31, 2011 -27,518.00%